- Home
- SXTC vs SRZN Comparison
SXTC vs SRZN Comparison
Compare SXTC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTC | SRZN |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.7M | 164.3M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SXTC | SRZN |
|---|---|---|
| Price | $0.09 | $20.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 21.4M | 69.7K |
| Earning Date | 08-19-2019 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,537,987.00 | ★ $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $5.90 |
| 52 Week High | $7.84 | $24.94 |
Technical Indicators
Market Signals| Indicator | SXTC | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 23.90 | 50.28 |
| Support Level | $0.09 | $17.98 |
| Resistance Level | $6.98 | $21.40 |
| Average True Range (ATR) | 0.58 | 1.93 |
| MACD | -0.11 | -0.26 |
| Stochastic Oscillator | 0.08 | 46.92 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).